IPT-based Group Intervention by Non-specialist for Improvement of Depressive Symptoms in Community Young Adults in Brazil
1 other identifier
interventional
50
1 country
1
Brief Summary
Major depressive disorder is a highly prevalent, recurrent, and debilitating disease, the third cause of years of lost life in the world, and it may be the most common disease in 2030, according to the World Health Organization (WHO). Furthermore, it's also related to decreased quality of life and high mortality. Interpersonal psychotherapy (IPT) is a first-line treatment and can also be used for the prevention of depression. This randomized controlled clinical trial is planned to have 50 participants randomized between an interventional and a control group (waiting list). Our study covers young adults (18 to 24 years old) with depression. Participants will be invited by social media to undergo treatment in an IPT group. The intervention group will be separated into groups with up to 10 participants, with a weekly meeting for eight weeks. The intervention will focus on interpersonal relationships within the model of IPT and will be held by a university student and a doctor trained in IPT.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable depression
Started Mar 2024
Longer than P75 for not_applicable depression
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2024
CompletedFirst Submitted
Initial submission to the registry
June 24, 2024
CompletedFirst Posted
Study publicly available on registry
June 28, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2028
April 13, 2026
October 1, 2025
2.8 years
June 24, 2024
April 8, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Hospital Anxiety and Depression Scale (HADS)
The Hospital Anxiety and Depression Scale consists of 14 items, of which 7 assess anxiety and 7 assess depression. Each item is scored from 0 to 3, and each subscale has a maximum score of 21 points with higher scores indicating greater symptom severity.
Pre-treatment, Week 1 to 8
Secondary Outcomes (5)
Patient Health Questionnaire-9
Pre-treatment, Week 1 to 8
Social support scale (MOS-SSS)
Pre-treatment, Week 1 to 8
Quality of Life (WHOQOL-BREF)
Pre-treatment, Week 1 to 8
Clinical Global Impression (CGI)
Pre-treatment, Week 1 to 8
Beck Depression Inventory (BDI)
Pre-treatment; Week 1-8
Other Outcomes (6)
Resilience (CD-RISC-10)
Pre-treatment, Week 1 to 8
Psychotherapy side effects (UE-ATR checklist)
Week 1 to 8
Childhood Trauma Questionnaire (CTQ)
Week 1
- +3 more other outcomes
Study Arms (2)
Intervention
OTHERParticipants that receive psychotherapy
Waiting list
NO INTERVENTIONParticipants that are waiting for intervention
Interventions
Interpersonal psychotherapy is a first-line treatment and can also be used for the prevention of depression.
Eligibility Criteria
You may qualify if:
- Young adults (between 18 and 24 years old)
- Young adults who work, live or study in Porto Alegre
- PHQ ≥ 5 - without suicide ideation
You may not qualify if:
- Maniac or hypomanic episode
- Psychotic Syndrome
- Substance Abuse
- Suicide Risk or Ideation
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Clinical Hospital for Porto Alegre
Porto Alegre, Rio Grande do Sul, 90035-903, Brazil
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
June 24, 2024
First Posted
June 28, 2024
Study Start
March 1, 2024
Primary Completion (Estimated)
December 31, 2026
Study Completion (Estimated)
December 31, 2028
Last Updated
April 13, 2026
Record last verified: 2025-10